In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biotechnology
UK-based antiviral drug discovery and development company reViral has announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014. 28 April 2014
Pharmaceutical
Chugai Pharma USA (CPUSA) has announced the appointment of Athos Gianella-Borradori as Chief Medical Officer. 25 April 2014
Biotechnology
Novartis Vaccines, the vaccination branch of Swiss drug major Novartis (NOVN: VX), has announced the appointment of Dr John Porter to the position of Medical Affairs Director for Cluster North Europe. 25 April 2014
Biotechnology
Digital medicines company Proteus Health, have announced the expansion of the company’s executive team and board of directors with the addition of three industry leaders across consumer technology and global pharmaceuticals. 25 April 2014
Biotechnology
China’s WuXi PharmaTech (NYSE: WX) has announced that Dr Steve Yang has joined the company as Executive Vice President and Chief Operating Officer. Edward Hu will assume new responsibilities as Chief Investment Officer and remain as Chief Financial Officer. 24 April 2014
Biotechnology
US generic drugmaker Impax Laboratories (NASDAQ: IPXL) has announced the appointment of Frederick Wilkinson as President and Chief Executive Officer effective April 29, 2014. 24 April 2014
Biotechnology
UK-based stem cell therapy company ReNeuron Group has announced the recruitment for a new Chief Executive Officer. 23 April 2014
Pharmaceutical
Pharma major Lupin has announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations. 23 April 2014
Pharmaceutical
Japanese drugmaker Daiichi Sankyo has announced that Ken Keller will join the company as President of its Commercial operations in the United States. 23 April 2014
Pharmaceutical
Swiss drug major Novartis has announced the appointment of Jeff George as Division Head of Alcon and Richard Francis as new Division Head of Sandoz. 22 April 2014
Pharmaceutical
UK-based drug discovery and development company e-Therapeutics has announced the appointment of Steve Medlicott as Finance Director. 22 April 2014
Pharmaceutical
South African drugmaker Adcock Ingram has announced the appointment of Kevin Wakeford (pictured) as Chief Executive Officer, with immediate effect. 22 April 2014
Pharmaceutical
French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier, has died at the age of 92. 17 April 2014
Pharmaceutical
The US subsidiary of Japanese drug major Astellas Pharma announced that Jeffrey Bloss has been promoted to the position of senior vice president, medical affairs Americas, Astellas Scientific and Medical Affairs (ASMA), effective April 1. Dr Bloss will serve as a member of the Astellas US management committee. 16 April 2014
Pharmaceutical
New Haven Pharmaceuticals, a privately held specialty pharmaceuticals company, today announced the appointment of Larry Dillaha, to the newly-created position of Executive Vice President Operations. 2 April 2014
Biotechnology
Paul Sekhri has joined French drug major Sanofi as Senior Vice President, Integrated Care effective today. 1 April 2014
Pharmaceutical
USA-based Inovio Pharmaceuticals (NYSE MKT: INO) has announced the appointment of EJ Brandreth as Vice President of Quality. 1 April 2014
Pharmaceutical
Par Pharmaceutical Companies (NYSE: PRX) has announced the appointment of Terrance Coughlin as chief operating officer. 1 April 2014
Biotechnology
French drug major Sanofi has announced the appointment of Anne Beal to the newly created position of Chief Patient Officer. 31 March 2014
Biotechnology
aTyr Pharma, a rare disease biotherapeutics enterprise, has announced the appointment of David Weiner as chief medical officer. 31 March 2014
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze